全文获取类型
| 收费全文 | 29784篇 |
| 免费 | 2074篇 |
| 国内免费 | 263篇 |
专业分类
| 耳鼻咽喉 | 458篇 |
| 儿科学 | 484篇 |
| 妇产科学 | 660篇 |
| 基础医学 | 4421篇 |
| 口腔科学 | 750篇 |
| 临床医学 | 2591篇 |
| 内科学 | 5907篇 |
| 皮肤病学 | 624篇 |
| 神经病学 | 2270篇 |
| 特种医学 | 1714篇 |
| 外科学 | 4639篇 |
| 综合类 | 318篇 |
| 一般理论 | 11篇 |
| 预防医学 | 1314篇 |
| 眼科学 | 744篇 |
| 药学 | 2488篇 |
| 1篇 | |
| 中国医学 | 279篇 |
| 肿瘤学 | 2448篇 |
出版年
| 2023年 | 154篇 |
| 2022年 | 343篇 |
| 2021年 | 801篇 |
| 2020年 | 439篇 |
| 2019年 | 738篇 |
| 2018年 | 797篇 |
| 2017年 | 646篇 |
| 2016年 | 765篇 |
| 2015年 | 1116篇 |
| 2014年 | 1398篇 |
| 2013年 | 1566篇 |
| 2012年 | 2348篇 |
| 2011年 | 2335篇 |
| 2010年 | 1426篇 |
| 2009年 | 1311篇 |
| 2008年 | 1815篇 |
| 2007年 | 1769篇 |
| 2006年 | 1642篇 |
| 2005年 | 1577篇 |
| 2004年 | 1437篇 |
| 2003年 | 1261篇 |
| 2002年 | 1103篇 |
| 2001年 | 790篇 |
| 2000年 | 769篇 |
| 1999年 | 632篇 |
| 1998年 | 247篇 |
| 1997年 | 229篇 |
| 1996年 | 194篇 |
| 1995年 | 165篇 |
| 1994年 | 140篇 |
| 1993年 | 115篇 |
| 1992年 | 251篇 |
| 1991年 | 187篇 |
| 1990年 | 182篇 |
| 1989年 | 170篇 |
| 1988年 | 150篇 |
| 1987年 | 106篇 |
| 1986年 | 97篇 |
| 1985年 | 75篇 |
| 1984年 | 83篇 |
| 1983年 | 56篇 |
| 1982年 | 53篇 |
| 1981年 | 51篇 |
| 1980年 | 43篇 |
| 1979年 | 58篇 |
| 1978年 | 46篇 |
| 1977年 | 47篇 |
| 1975年 | 41篇 |
| 1972年 | 46篇 |
| 1971年 | 47篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
Vilar-Compte Mireya Gaitán-Rossi Pablo Félix-Beltrán Lucía Bustamante Arturo V. 《Journal of immigrant and minority health / Center for Minority Public Health》2022,24(1):65-77
Journal of Immigrant and Minority Health - COVID-19 has disproportionally affected underrepresented minorities (URM) and low-income immigrants in the United States. The aim of the study is to... 相似文献
2.
Autoimmune comorbid diseases associated with lichen planus: a nationwide case–control study 
下载免费PDF全文
下载免费PDF全文 3.
4.
5.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献6.
7.
Micro‐evolution of the hepatitis B virus genome in hepatitis B e‐antigen‐positive carriers: Comparison of genotypes B and C at various immune stages 下载免费PDF全文
下载免费PDF全文 8.
Miju Bae Sung Woon Chung Chung Won Lee Up Huh Min Su Kim Seung Hwan Song 《Asian journal of surgery / Asian Surgical Association》2019,42(1):235-239
Background
In Leriche syndrome, postoperative graft thrombosis remains one of the most significant clinical challenges.Methods
We reviewed 51 patients who underwent surgery for aortoiliac occlusive disease at our hospital from January 2007 to December 2014. The factors associated with graft patency were determined using the Cox proportional hazard model.Results
The 2-year prosthetic graft patency rate was 72.5%. Younger age (p = 0.017, Odd ratio (OR) = 1.112), postoperative uncontrolled hypertension (p = 0.044, OR = 3.797), and associated Trans Atlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease II (TASC II) D femoropopliteal lesion (p = 0.008, OR = 11.139) were significantly related factors for prosthetic graft patency after surgical repair. The existing comorbidities of the patients that indicated the need for axillo-bifemoral bypass seemed to be related to lower graft patency or other complications.Conclusions
For better graft patency after an open surgical repair of Leriche syndrome, strict postoperative hypertension control and distal run-off resolution are necessary. 相似文献9.
Diabetes mellitus(DM) negatively affects the development and progression of chronic liver diseases(CLD) of various etiologies. Concurrent DM and CLD are also associated with worse clinical outcomes with respect to mortality, the occurrence of hepatic decompensation, and the development of hepatocellular carcinoma(HCC). Unfortunately, early diagnosis and optimal treatment of DM can be challenging, due to the lack of established clinical guidelines as well as the medical complexity of this patient population. We conducted an exploratory review of relevant literature to provide an up-to-date review for internists and hepatologists caring for this patient population. We reviewed the epidemiological and pathophysiological associations between DM and CLD, the impact of insulin resistance on the progression and manifestations of CLD, the pathogenesis of hepatogenic diabetes, as well as the practical challenges in diagnosis and monitoring of DM in this patient population. We also reviewed the latest clinical evidence on various pharmacological antihyperglycemic therapies with an emphasis on liver disease-related clinical outcomes. Finally, we proposed an algorithm for managing DM in patients with CLD and discussed the clinical and research questions that remain to be addressed. 相似文献